Skip to main content
SpringerLink
Log in

Zystektomie — Harnableitung — Chemotherapie

Management des muskelinvasiven Harnblasenkarzinoms

Management of muscle invasive cancer of the urinary bladder

  • FORTBILDUNG . SCHWERPUNKT
  • Published:
MMW - Fortschritte der Medizin Aims and scope

Wird ein muskelinvasiver oder ein therapieresistenter nicht-muskelinvasiver Blasentumor diagnostiziert, steht dem Patienten eine radikale Zystektomie bevor. Um sich für eine in der Folge notwendige Form der Harnableitung entscheiden zu können, muss der Patient im Vorfeld ausführlich über die jeweiligen Vor- und Nachteile aufgeklärt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2

Literatur

  1. Ahmadi H, Lee CT (2015) Health-related quality of life with urinary diversion. Curr Opin Urol 25:562–569

    Article  Google Scholar 

  2. Ali AS, Hayes MC, Birch B et al (2015) Health related quality of life (HRQoL) after cystectomy: comparison between orthotopic neobladder and ileal conduit diversion. Eur J Surg Oncol 41:295–299

    Article  CAS  Google Scholar 

  3. Aziz A, May M, Burger M et al (2014) Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Eur Urol 66:156–163

    Article  Google Scholar 

  4. Bochner BH, Sjoberg DD, Laudone VP et al (2014) A randomized trial of robot-assisted laparoscopic radical cystectomy. N Engl J Med 371:389–390

    Article  CAS  Google Scholar 

  5. Buchner A, Grimm T, Schneevoigt BS et al (2017) Dramatic impact of blood transfusion on cancer-specific survival after radical cystectomy irrespective of tumor stage. Scand J Urol 51:130–136

    Article  Google Scholar 

  6. Cody JD, Nabi G, Dublin N et al (2012) Urinary diversion and bladder reconstruction/replacement using intestinal segments for intractable incontinence or following cystectomy. Cochrane Database Syst Rev. https://doi-org.emedien.ub.uni-muenchen.de/10.1002/14651858.CD003306.pub2

  7. Geschwend JE, Heck MM, Lehmann J et al (2016) Limited versus extended pelvic lymphadenectomyin patients with bladder cancer undergoing radical cystectomy: survival results from randomized trail (LEA AUO AB 25/02, NCTO1215071). JCO 34(suppl):abstr 4503

  8. Gierth M, Mayr R, Aziz A et al (2015) Preoperative anemia is associated with adverse outcome in patients with urothelial carcinoma of the bladder following radical cystectomy. J Cancer Res Clin Oncol 141:1819–1826

    Article  CAS  Google Scholar 

  9. Goossens-Laan CA, Leliveld AM, Verhoeven RH et al (2014) Effects of age and comorbidity on treatment and survival of patients with muscle-invasive bladder cancer. Int J Cancer 135:905–912

    Article  CAS  Google Scholar 

  10. Gschwend J, Retz M, Kuebler H (2010) Indications and oncological outcome of radical cystectomy for urothelial bladder cancer. Eur Urol 9:10–18

    Article  Google Scholar 

  11. Karl A, Rittler P, Buchner A et al (2009) Prospective assessment of malnutrition in urologic patients. Urology 73:1072–1076

    Article  Google Scholar 

  12. Karl A, Buchner A, Becker A et al (2014) A new concept for early recovery after surgery for patients undergoing radical cystectomy for bladder cancer: results of a prospective randomized study. J Urol 191:335–340

    Article  CAS  Google Scholar 

  13. Pang KH, Groves R, Venugopal S et al (2017) Prospective implementation of enhanced recovery after surgery protocols to radical cystectomy. Eur Urol pii:S0302-2838(17)30660-7. https://doi-org.emedien.ub.uni-muenchen.de/10.1016/j.eururo.2017.07.031

  14. Roghmann F, Ravi P, Hanske J et al (2015) Perioperative outcomes after radical cystectomy at NCI-designated centres: are they any better? Can Urol Assoc J 9:207–212

    Article  Google Scholar 

  15. Tyritzis SI, Wiklund NP (2018) Is the open cystectomy era over? An update on the available evidence. Int J Urol 25(3):187. https://doi-org.emedien.ub.uni-muenchen.de/10.1111/iju.13497

  16. Udovicich C, Perera M, Huq M et al (2017) Hospital volume and perioperative outcomes for radical cystectomy: a population study. BJU Int 119(Suppl 5):26–32

    Article  Google Scholar 

  17. Witjes AJ, Lebret T, Comperat EM et al (2017) Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur Urol 71:462–475

    Article  Google Scholar 

  18. Xia L, Guzzo TJ (2017) Preoperative anemia and low hemoglobin level are associated with worse clinical outcomes in patients with bladder cancer undergoing radical cystectomy: a Meta-analysis. Clin Genitourin Cancer 15:263–272.e4

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Urologie, Barmherzige Brüder München, Romanplatz 93, D-80639, München, Deutschland

    Alexander Karl (Chefarzt)

Authors
  1. Alexander Karl
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alexander Karl.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karl, A. Management des muskelinvasiven Harnblasenkarzinoms. MMW - Fortschritte der Medizin 160, 46–50 (2018). https://doi.org/10.1007/s15006-018-1235-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-018-1235-0

Keywords

Search

Navigation